Fig. 2From: Comparison of first-line chemotherapy based on irinotecan or other drugs to treat non-small cell lung cancer in stage IIIB/IV: a systematic review and meta-analysisComparison of overall response rate between irinotecan-based chemotherapy and non-irinotecan-based chemotherapy as first-line treatment in patients with stage IIIB/IV NSCLCBack to article page